These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21030327)

  • 21. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.
    Ferrario CM; Joyner J; Colby C; Exuzides A; Moore M; Simmons D; Bestermann W; Frech-Tamas F
    Vasc Health Risk Manag; 2013; 9():391-400. PubMed ID: 23901282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.
    Rückert IM; Schunk M; Holle R; Schipf S; Völzke H; Kluttig A; Greiser KH; Berger K; Müller G; Ellert U; Neuhauser H; Rathmann W; Tamayo T; Moebus S; Andrich S; Meisinger C
    Cardiovasc Diabetol; 2012 May; 11():50. PubMed ID: 22569118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
    Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
    Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE.
    Gitt AK; Schmieder RE; Duetting E; Bramlage P; Schneider S; Tschöpe D;
    Cardiovasc Diabetol; 2012 Dec; 11():148. PubMed ID: 23216660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.
    Park JE; Chiang CE; Munawar M; Pham GK; Sukonthasarn A; Aquino AR; Khoo KL; Chan HW
    Eur J Prev Cardiol; 2012 Aug; 19(4):781-94. PubMed ID: 21450606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
    Schmittdiel JA; Uratsu CS; Karter AJ; Heisler M; Subramanian U; Mangione CM; Selby JV
    J Gen Intern Med; 2008 May; 23(5):588-94. PubMed ID: 18317847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
    Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
    Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cardiovascular risk factors after renal transplantation: a step towards reducing graft failure.
    Kumar R; Brar J; Yacoub R; Khan T; Zachariah M; Venuto R
    Transplant Proc; 2012 Jun; 44(5):1270-4. PubMed ID: 22663999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting.
    Kirk JK; Huber KR; Clinch CR
    N C Med J; 2005; 66(6):415-9. PubMed ID: 16438097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.
    Fretheim A; Oxman AD; Håvelsrud K; Treweek S; Kristoffersen DT; Bjørndal A
    PLoS Med; 2006 Jun; 3(6):e134. PubMed ID: 16737346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.
    Di Martino M; Degli Esposti L; Filigheddu F; Veronesi C; Salerno G; Saragoni S; Glorioso N; Didoni G; Degli Esposti E
    J Hum Hypertens; 2007 Jan; 21(1):53-9. PubMed ID: 17036042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalised treatment targets in type 2 diabetes patients: The Dutch approach.
    Boels AM; Hart HE; Rutten GE; Vos RC
    Prim Care Diabetes; 2017 Feb; 11(1):71-77. PubMed ID: 27633894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
    Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
    Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study.
    Bała MM; Leśniak W; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Kardiol Pol; 2011; 69(12):1249-57. PubMed ID: 22219100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis.
    Trimarco V; Battistoni A; Tocci G; Coluccia R; Manzi MV; Izzo R; Volpe M
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):850-857. PubMed ID: 28965797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and control of type 2 diabetes mellitus among primary care physicians in Spain. PRISMA Study.
    Franch-Nadal J; Mediavilla-Bravo J; Mata-Cases M; Mauricio D; Asensio D; Sarroca J
    Endocrinol Diabetes Nutr; 2017 May; 64(5):265-271. PubMed ID: 28495322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.